Media alert: Anthony S. Fauci, M.D., to address American Heart Association Scientific Sessions 2020

DALLAS, Nov. 13, 2020 – Anthony S. Fauci, M.D., the top infectious disease expert in the U.S., will present at the American Heart Association’s Scientific Sessions 2020. His recorded remarks, titled, “COVID-19: Public Health and Scientific Challenges,” is a keynote presentation featured on Tuesday, November 17 at 10:30 a.m. Central Time/11:30 a.m. Eastern Time. The…

Examining impact of a point mutation in SARS-Cov-2 spike on virus transmission and pathogenicity

The current dominant variant of SARS-CoV-2, containing a D614G substitution in the spike protein, appears to have evolved to enhance transmissibility, according to a new study in human cells and animal models. Its results address concerns that have been raised about how this emergent mutation could enhance transmissibility, antigenicity, and/or pathogenesis, with implications for therapies…

JAMA reports fluvoxamine as potential early treatment for COVID-19

SAN FRANCISCO – Nov. 12, 2020 – The COVID-19 Early Treatment Fund (CETF), today announced that JAMA, The Journal of the American Medical Association, published the results of a Washington University School of Medicine in St. Louis double-blind, randomized controlled clinical trial that investigated whether the antidepressant medication fluvoxamine, if taken within seven days of…

San Diego zoo global biobanking advances wildlife conservation and human medicine worldwide

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250. The results of the mammal genome project, published in the Nov. 12 issue of the journal Nature, catalog and characterize whole branches of Earth’s biodiversity,…